Agence France-PresseMay 17, 2013 16:46
Europe's medicines watchdog said Friday the benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins -- when correctly prescribed.
The clot risk was "low", said a European Medicines Agency (EMA) ruling on a French-initiated review of the drug's safety.
But it stressed Diane-35 and its generics should be used only for acne treatment, as indicated by the pill's German manufacturer, Bayer.
Follow us: